BP
BioCryst Pharmaceuticals, Inc. - Common Stock
BCRX
Close · 10/09/2026
8.29
1D
-5.90%52-week range
6 – 11.22
Volume
90,00,900.00
Price history
BCRX
11/08/2026 to 10/09/2026
O 8.34 H 8.46 L 8.05
1W-18.49%
1M-19.83%
3M+1.22%
6M-2.36%
1Y+2.60%
3Y+17.59%
5Y-48.67%
MAX-48.98%
Fundamentals
as of 10/09/2026- Market cap
- $2.12B
- Shares out
- 255.54M
- P/E (forward)
- 10.60
- EPS (trailing)
- -1.51
- Beta
- 0.56
- Profit margin
- -40.90%
- P/B
- -5.60
SEC financial statements
59 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- BCRX
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
2 filers · 1 on watchlist · 4 buys · 1 sell · D: 5
- 10/07/2026Gilbert CisnerosBuyBioCryst Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 13/11/2025Gilbert CisnerosBuyBioCryst Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 16/10/2023Josh GottheimerWBuyBioCryst Pharmaceuticals, Inc.$1,001–$15,000
- 15/09/2023Josh GottheimerWSellBioCryst Pharmaceuticals, Inc.$1,001–$15,000
- 11/08/2022Josh GottheimerWBuyBioCryst Pharmaceuticals, Inc.$1,001–$15,000